Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Interest Expense : ¥-28.5 Mil (TTM As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is Beijing Bohui Innovation Biotechnology Group Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Beijing Bohui Innovation Biotechnology Group Co's interest expense for the three months ended in Mar. 2025 was ¥ -6.3 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-28.5 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Beijing Bohui Innovation Biotechnology Group Co's Operating Income for the three months ended in Mar. 2025 was ¥ 11.2 Mil. Beijing Bohui Innovation Biotechnology Group Co's Interest Expense for the three months ended in Mar. 2025 was ¥ -6.3 Mil. Beijing Bohui Innovation Biotechnology Group Co's Interest Coverage for the quarter that ended in Mar. 2025 was 1.80. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Beijing Bohui Innovation Biotechnology Group Co Interest Expense Historical Data

The historical data trend for Beijing Bohui Innovation Biotechnology Group Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Bohui Innovation Biotechnology Group Co Interest Expense Chart

Beijing Bohui Innovation Biotechnology Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-35.44

-0.52

-41.78

-26.35

-27.77

Beijing Bohui Innovation Biotechnology Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Expense	Get a 7-Day Free Trial															-5.57	-4.77	-7.28	-10.15	-6.26

Beijing Bohui Innovation Biotechnology Group Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-28.5 Mil.

Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Beijing Bohui Innovation Biotechnology Group Co's Interest Expense for the three months ended in Mar. 2025 was ¥-6.3 Mil. Its Operating Income for the three months ended in Mar. 2025 was ¥11.2 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was ¥704.5 Mil.

Beijing Bohui Innovation Biotechnology Group Co's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2025 )	/	Interest Expense (Q: Mar. 2025 )
	=	-1	*	11.248	/	-6.26
	=	1.80

The higher the ratio, the stronger the company's financial strength is.

Warning Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Beijing Bohui Innovation Biotechnology Group Co Ltds earnings cannot cover its interest expense. If the situation continues, the company may have to issue more debt.

Beijing Bohui Innovation Biotechnology Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Bohui Innovation Biotechnology Group Co Ltd (SZSE:300318) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Block G Jingxinyuan, NO.25 Jia Beiwucun Road, Haidian, Beijing, CHN, 100097

Website

http://www.bohui-tech.com

Beijing Bohui Innovation Biotechnology Group Co Ltd is a high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. The company focuses on the research and development, production, sales, and after-sales services of in vitro diagnostic products. The Company's business involved two segments: inspection and testing and biological products. The Biological segment generated the majority of its revenue which engaged in the research and development, production, and sales of blood products, the product range covers human blood albumin, human immunoglobulin, and human coagulation factor three categories of multiple varieties, basically covering the important varieties of blood products.

Executives

Niu Shu Hui	Executives
Di Xiao Feng	Director
Yang Qi	Director
Lu Xin Qun	Directors, executives
Zhang Lei	Director
Wan Zhang Geng	Executives
Song Rui	Directors, executives

Beijing Bohui Innovation Biotechnology Group Co Headlines

No Headlines